2021
DOI: 10.3390/jpm11020142
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Somatic Structural Variants in Solid Tumors by Optical Genome Mapping

Abstract: Genomic structural variants comprise a significant fraction of somatic mutations driving cancer onset and progression. However, such variants are not readily revealed by standard next-generation sequencing. Optical genome mapping (OGM) surpasses short-read sequencing in detecting large (>500 bp) and complex structural variants (SVs) but requires isolation of ultra-high-molecular-weight DNA from the tissue of interest. We have successfully applied a protocol involving a paramagnetic nanobind disc to a wide r… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
24
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(27 citation statements)
references
References 46 publications
2
24
1
Order By: Relevance
“…Additionally, we analyzed each genome for all clinically relevant SVs, and report findings as “concordant” to previous SOC results and “additional findings” that were not reported with SOC methods ( Supplementary file 1) . Although detailed investigation and confirmation of these additional findings remain beyond the scope of this manuscript, we have provided all clinically reportable SVs in Supplementary file 1 to assist future discoveries and consider these findings as likely true events, consistent with previous reports [ 16 , 17 ].…”
Section: Methodssupporting
confidence: 69%
See 1 more Smart Citation
“…Additionally, we analyzed each genome for all clinically relevant SVs, and report findings as “concordant” to previous SOC results and “additional findings” that were not reported with SOC methods ( Supplementary file 1) . Although detailed investigation and confirmation of these additional findings remain beyond the scope of this manuscript, we have provided all clinically reportable SVs in Supplementary file 1 to assist future discoveries and consider these findings as likely true events, consistent with previous reports [ 16 , 17 ].…”
Section: Methodssupporting
confidence: 69%
“…The variants from the two algorithms are simultaneously visualized in a unique analysis tool for ease of interpretation, variant classification, and reporting (Bionano access 1.6 software). Recently, the technology has gained enormous traction and has been evaluated in several settings, including prenatal [ 14 ], postnatal [ 15 ], hematological neoplasms [ 16 ], and solid tumors [ 17 ], demonstrating 100% clinical concordance with traditional cytogenetic analysis. However, the literature lacks any clinical validation studies, which are critical for comprehensive evaluation and clinical implementation.…”
Section: Introductionmentioning
confidence: 99%
“…More complex events, known as chromoanagenesis, combine a cascade of chromosomal rearrangements 1 . Over the past few years, structural variants and complex genomic rearrangements have been implicated in various phenotypes: cancer 2 , 3 , rare disorders 4 9 and common diseases 10 in humans, reproduction traits in pigs 11 , virulence traits in plant pathogenic fungi 12 , local adaptation in maize 13 , and behavior in Caenorhabditis elegans ( C. elegans ) 14 . However, the technologies and methods used to identify SVs and complex rearrangements are still multifaceted and no approach has yet been recognized as standard.…”
Section: Introductionmentioning
confidence: 99%
“…These images are then processed into label coordinates per DNA molecule, typically ranging from 100kb up to several Mb. This data can then either be used to scaffold existing sequence-based assemblies [ 12 15 ], or directly assembled into consensus optical maps which can help detect structural variation [ 16 19 ].…”
Section: Introductionmentioning
confidence: 99%